Expression and clinical significance of cyclooxygenase-2 and microRNA-143 in osteosarcoma

Fang,Yongchao; Zhang,Zhiqiang; Wang,Qiang; Zhao,Jianning

doi:10.3892/etm.2015.2420

June-2015 Volume 9 Issue 6

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

June-2015 Volume 9 Issue 6

Full Size Image

Article

Expression and clinical significance of cyclooxygenase-2 and microRNA-143 in osteosarcoma

Authors:
- Yongchao Fang
- Zhiqiang Zhang
- Qiang Wang
- Jianning Zhao
View Affiliations / Copyright

Affiliations: Department of Orthopedic Surgery, Jinling Hospital, Southern Medical University, Nanjing, Jiangsu 210002, P.R. China
Pages: 2374-2378
|
Published online on: April 14, 2015

https://doi.org/10.3892/etm.2015.2420
Expand metrics +

Abstract

The aim of the present study was to investigate the expression profiles of cyclooxygenase (COX)-2 and microRNA (miRNA)-143 in the tumor tissue and blood samples of patients with osteosarcoma, and their involvement in the disease pathogenesis. Tumor tissue and blood samples were obtained from 46 patients with osteosarcoma (stages I‑III). Reverse transcription‑quantitative polymerase chain reaction (RT‑qPCR) and western blot analyses were performed to detect the mRNA and protein expression of COX‑2, respectively, in these samples. The expression of miRNA‑143 in the tumor tissue and blood samples was assessed using RT‑qPCR. The results showed that, compared with the normal control subjects, the mRNA and protein expression levels of COX‑2 in the tumor tissue and blood samples of patients with osteosarcoma were increased. Among the patients with osteosarcoma, increases in the COX‑2 mRNA and protein levels were observed with progressing disease severity (from stage I to stage III), suggesting the involvement of COX‑2 in the disease pathogenesis. By contrast, the expression of miRNA‑143 decreased as the disease progressed, which was the opposite trend to the COX‑2 expression, indicating that miRNA‑143 and COX‑2 may play different roles in the disease pathogenesis. In conclusion, COX‑2 expression in the tumor tissue and blood samples of patients with osteosarcoma increases significantly along with the degree of tumor malignancy, and this is accompanied by a decreased expression of miRNA-143; therefore, a negative correlation between COX-2 and miRNA-143 may exist in the progression of osteosarcoma.

View Figures

View References

1	Lei P, Xie J, Wang L, Yang X, Dai Z and Hu Y: microRNA-145 inhibits osteosarcoma cell proliferation and invasion by targeting ROCK1. Mol Med Rep. 10:155–160. 2014.PubMed/NCBI
2	Clark JC, Dass CR and Choong PF: A review of clinical and molecular prognostic factors in osteosarcoma. J Cancer Res Clin Oncol. 134:281–297. 2008. View Article : Google Scholar : PubMed/NCBI
3	Kansara M and Thomas DM: Molecular pathogenesis of osteosarcoma. DNA Cell Biol. 26:1–18. 2007. View Article : Google Scholar : PubMed/NCBI
4	Cai ZD and Li GD: Ezrin protein: Novel hot point of research on mechanism of neoplasm metastasis. Zhonghua Zhong Liu Za Zhi. 6:3223252005.(In Chinese).
5	Gorlick R and Khanna C: Osteosarcoma. J Bone Miner Res. 25:683–691. 2010. View Article : Google Scholar : PubMed/NCBI
6	Ottaviani G and Jaffe N: The etiology of osteosarcoma. Cancer Treat Res. 152:15–32. 2009. View Article : Google Scholar : PubMed/NCBI
7	Kansara M, Leong HS, Lin DM, et al: Immune response to RB1-regulated senescence limits radiation-induced osteosarcoma formation. J Clin Invest. 123:5351–5360. 2013. View Article : Google Scholar : PubMed/NCBI
8	Zhou X, Jing J, Peng J, et al: Expression and clinical significance of galectin-3 in osteosarcoma. Gene. 546:403–407. 2014. View Article : Google Scholar : PubMed/NCBI
9	Wu X, Cai M, Ji F and Lou LM: The impact of COX-2 on invasion of osteosarcoma cell and its mechanism of regulation. Cancer Cell Int. 14:272014. View Article : Google Scholar : PubMed/NCBI
10	Wu XL, Cheng B, Li PY, et al: MicroRNA-143 suppresses gastric cancer cell growth and induces apoptosis by targeting COX-2. World J Gastroenterol. 19:7758–7765. 2013. View Article : Google Scholar : PubMed/NCBI
11	Pham H, Rodriguez CE, Donald GW, et al: miR-143 decreases COX-2 mRNA stability and expression in pancreatic cancer cells. Biochem Biophys Res Commun. 439:6–11. 2013. View Article : Google Scholar : PubMed/NCBI
12	Song T, Zhang X, Wang C, et al: Expression of miR-143 reduces growth and migration of human bladder carcinoma cells by targeting cyclooxygenase-2. Asian Pac J Cancer Prev. 12:929–933. 2011.PubMed/NCBI
13	Yamasaki L: Role of RB tumor suppressor in cancer. Cancer Treat Res. 115:209–239. 2003. View Article : Google Scholar : PubMed/NCBI
14	Jaffe N: Osteosarcoma. Pediatr Rev. 12:333–343. 1991.PubMed/NCBI
15	Alhouayek M and Muccioli GG: COX-2-derived endocannabinoid metabolites as novel inflammatory mediators. Trends Pharmacol Sci. 35:284–292. 2014. View Article : Google Scholar : PubMed/NCBI
16	Wang L, Wang Z, Li J, et al: NFATc1 activation promotes the invasion of U251 human glioblastoma multiforme cells through COX-2. Int J Mol Med. Mar 4–2015.(Epub ahead of print). doi. View Article : Google Scholar
17	Wu K, Fukuda K, Xing F, et al: Roles of the cyclooxygenase 2-matrix metalloproteinase 1 pathway in brain metastasis of breast cancer. J Biol Chem. Feb 17–2015.(Epub ahead of print). pii: jbc.M114.602185. View Article : Google Scholar
18	Toujas L, Delcros J G, Diez E, et al: Human monocyte-derived macrophages and dendritic cells are comparably effective in vitro in presenting HLA class I-restricted exogenous peptides. Immunol. 91:635–642. 1997. View Article : Google Scholar

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

Expression and clinical significance of cyclooxygenase-2 and microRNA-143 in osteosarcoma

This article is mentioned in:

Abstract

Figure 1

Figure 2

Figure 3

Related Articles